Antimycobacterial 3-aryl-2H-1,3-benzoxazine-2,4(3H)-diones

Area of Science:

• Medicinal Chemistry
• Organic Synthesis
• Microbiology

Background:

• Tuberculosis and related mycobacterial infections remain significant global health challenges.
• Developing novel antimycobacterial agents is crucial to combat drug resistance.
• Benzoxazine derivatives represent a promising scaffold for drug discovery.

Purpose of the Study:

• To synthesize a library of 3-phenyl-2H-benzoxazine-2,4(3H)-dione derivatives.
• To evaluate the in vitro antimycobacterial activity of these compounds against Mycobacterium tuberculosis, Mycobacterium kansasii, and Mycobacterium avium.
• To establish structure-activity relationships for this class of compounds.

Main Methods:

• Synthesis of 153 derivatives with variations at positions 6 or 7 of the benzoxazine ring and on the phenyl ring.
• In vitro antimycobacterial activity testing using standard microbiological assays.
• Analysis of substituent effects on biological activity.

Main Results:

• The synthesized compounds exhibited varying degrees of antimycobacterial activity.
• Activity generally increased with enhanced hydrophobicity of phenyl ring substituents.
• Electron-withdrawing substituents on the phenyl ring also correlated with increased activity.
• The influence of substituents on the benzoxazine core was more complex and less predictable.

Conclusions:

• The 3-phenyl-2H-benzoxazine-2,4(3H)-dione scaffold is a viable platform for developing antimycobacterial agents.
• Hydrophobicity and electronic properties of phenyl ring substituents are key determinants of antimycobacterial efficacy.
• Further optimization focusing on phenyl ring modifications could lead to potent drug candidates.